Following laboratory testing, data shows that whilst a two-dose primary course of the Spikevax (Moderna) vaccine resulted in a low generation of neutralising antibodies against the Omicron variant, a booster dose provided a 37-fold increase in neutralising antibodies. 


For more information on these findings refer to the full article via the link below:

Moderna COVID-19 vaccine booster dose ‘appears protective against Omicron’